Safety and Efficacy of Propranolol in the Treatment of Tardive Dyskinesia

NCT03254186 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No participants

Conditions

Tardive Dyskinesia

Interventions

DRUG: Propranolol Hydrochloride
DRUG: Placebo Oral Tablet

Sponsor

Emory University

Collaborators

[object Object]